Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H, Taniguchi H
Department of Gastrointestinal Oncology, Center for Adult Diseases, Osaka, Japan.
Cancer. 1994 Apr 1;73(7):1795-9. doi: 10.1002/1097-0142(19940401)73:7<1795::aid-cncr2820730704>3.0.co;2-x.
Using prospective follow-up studies, the authors examined the value of the expression of c-myc mRNA in biopsy specimens obtained from elevated gastric lesions as an aid in the differentiating between adenomas and well differentiated elevated-type adenocarcinomas.
By in situ hybridization, the authors determined the expression of c-myc mRNA in biopsy specimens of elevated gastric lesions. The 31 patients who had borderline lesions with and without overexpression of c-myc were followed with repeated endoscopic examinations and gastric biopsies.
Endoscopic follow-up examinations showed that gastric cancer was detected in 5 of 11 patients (46%) with elevated lesions that stained positively for c-myc mRNA during an observation period of 15 months (range, 2-32 months). The cancers were confirmed histologically in gastrectomy specimens. No cancers were found in patients with elevated lesions that stained negatively. The difference was statistically significant (P < 0.01).
The overexpression of c-myc mRNA may present a new tool for distinguishing between adenomas and well differentiated adenocarcinomas of the elevated type.
通过前瞻性随访研究,作者检测了取自胃隆起性病变活检标本中c-myc mRNA的表达情况,以辅助鉴别腺瘤与高分化隆起型腺癌。
作者通过原位杂交法测定胃隆起性病变活检标本中c-myc mRNA的表达。对31例c-myc有或无过表达的临界病变患者进行重复内镜检查及胃活检随访。
内镜随访检查显示,在15个月(范围2 - 32个月)的观察期内,11例c-myc mRNA染色阳性的隆起性病变患者中有5例(46%)检测到胃癌,胃癌在胃切除标本中经组织学证实。c-myc mRNA染色阴性的隆起性病变患者未发现癌症。差异具有统计学意义(P < 0.01)。
c-myc mRNA的过表达可能为鉴别隆起型腺瘤与高分化腺癌提供一种新工具。